Cladribine repurposed in multiple sclerosis: making a fortune out of a generic drug

被引：1
|
作者：
Buiter, Hans J. C. [1 ]
Derijks, Luc [2 ]
Mulder, Chris J. J. [3 ]
机构：
[1] Univ Amsterdam, Med Ctr, Dept Clin Pharmacol & Pharm, Amsterdam, Netherlands
[2] Maxima Med Ctr, Dept Clin Pharm & Pharmacol, Veldhoven, Netherlands
[3] Univ Amsterdam, Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF HOSPITAL PHARMACY | 2019年 / 26卷 / 05期
关键词：
Purine nucleoside analogues; cladribine; multiple sclerosis; subcutaneous; cost; drug; re-discovery; off-label; immune suppression; DMT;
D O I：
10.1136/ejhpharm-2019-002026
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：246 / 247
页数：2
相关论文
共 50 条
  • [21] Cladribine to Treat Relapsing Forms of Multiple Sclerosis
    Giovannoni, Gavin
    NEUROTHERAPEUTICS, 2017, 14 (04) : 874 - 887
  • [22] Cladribine: An Investigational immunomodulatory agent for multiple sclerosis
    Brousil, Julie A.
    Roberts, Russel J.
    Schlein, Amanda L.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (10) : 1814 - 1821
  • [23] Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis
    Radojka M. Savic
    Ana M. Novakovic
    Marianne Ekblom
    Alain Munafo
    Mats O. Karlsson
    Clinical Pharmacokinetics, 2017, 56 : 1245 - 1253
  • [24] Cladribine personalised dosing to treat multiple sclerosis
    Mao, Z.
    Alvarez-Gonzalez, C.
    Allen-Philbey, K.
    Turner, B.
    Gnanapavan, S.
    Marta, M.
    Mathews, J.
    Giovannoni, G.
    Baker, D.
    Schmierer, K.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 609 - 609
  • [25] Cladribine - A review of its use in multiple sclerosis
    Langtry, HD
    Lamb, HM
    BIODRUGS, 1998, 9 (05) : 419 - 433
  • [26] Cladribine to Treat Relapsing Forms of Multiple Sclerosis
    Gavin Giovannoni
    Neurotherapeutics, 2017, 14 : 874 - 887
  • [27] The treatment of chronic progressive multiple sclerosis with cladribine
    Beutler, E
    Sipe, JC
    Romine, JS
    Koziol, JA
    McMillan, R
    Zyroff, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) : 1716 - 1720
  • [28] Medicinal Chemistry of Multiple Sclerosis: Focus on Cladribine
    Biernacki, Tamas
    Sandi, Daniel
    Bencsik, Krisztina
    Vecsei, Laszlo
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (04) : 269 - 285
  • [29] Development of oral cladribine for the treatment of multiple sclerosis
    Hans-Peter Hartung
    Orhan Aktas
    Bernd Kieseier
    Giancarlo Comi
    Journal of Neurology, 2010, 257 : 163 - 170
  • [30] PERSONALISED DOSING OF CLADRIBINE TO TREAT MULTIPLE SCLEROSIS
    Mao, Zhifeng
    Alvarez-Gonzalez, Cesar
    Allen-Philbey, Kimberley
    Mathews, Joela
    Turner, Benjamin P.
    Gnanapavan, Sharmilee
    Marta, Monica
    Baker, David
    Giovannoni, Gavin
    Schmierer, Klaus
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A47 - A48
12345